Navigation Links
BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
Date:11/13/2007

NEW HAVEN, CT, and TORONTO, Nov. 13 /PRNewswire/ - BioRelix, pioneers in the discovery and development of RiboSwitch based therapeutic agents and Dalton Medicinal Chemistry, have jointly announced a research collaboration to discover new therapeutics.

Dalton Medicinal Chemistry will utilize their proprietary insights to design and synthesize several novel classes of compounds against selected RiboSwitch targets. BioRelix will advance these compounds using their cutting edge battery of biological assays and thorough knowledge of RiboSwitch drug discovery and development.

Brian Dixon, BioRelix CEO commented: "We are pleased to have the opportunity to work with the creative team at Dalton Medicinal Chemistry in the discovery of new entities for treating infectious diseases. Their expertise, coupled with our proprietary and leading position in RiboSwitch technology will lead to important new medicines."

Judd Berman, Co-founder of Dalton Medicinal Chemistry, said: "We are delighted to have this opportunity to work with BioRelix in the discovery of much needed new anti-infective agents. The team at BioRelix has clearly established an exceptionally innovative approach to anti-infectives."

About BioRelix

BioRelix Pharmaceuticals, Inc. is a drug discovery and development company focused on identifying new anti-infective drug treatments. BioRelix is building a portfolio of anti-infective products based on novel patented RNA targets, termed RiboSwitches, which were identified in the laboratory of BioRelix co-founder, Ronald Breaker Ph.D., Howard Hughes Investigator and Henry Ford II Professor at Yale University. BioRelix investors include CHL Medical Partners, New Leaf Venture Partners, Aisling Capital, Novartis Venture Fund, Elm Street Ventures and Alexandria Real Estate Equities.

About Dalton Pharma Services

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufac
'/>"/>

SOURCE Dalton Pharma Services
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
2. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
3. Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
4. Argonne scientist to give the plenary talk at Royal Society of Chemistry meeting on nanoalloys
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
8. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
9. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTher...lpresentatthe21stAnnualPiperJaffrayHealthCareConfe...eNewYorkPalaceHotel. ,, CTIwillpresentonTuesday...).AliveaudiowebcastofCTI,spresentationwillbeavaila...ilableforreplayafterwards. , ,PiperJaffrayHealthC...
(Date:11/23/2009)...antum computing promises ultra-fast communication,...sitive information. But trying to use quantum stat...cate business. Now two physicists have shown, math... in quantum communication, while keeping the infor...nt issue of Physical Review Letters and highligh...
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YM...esproductdevelopmentcompanythatidentifiesandadvanc...tsatvariousstagesofdevelopment,todayreportedthatCy...ialevaluatingCYT387,apotent,orally-administeredJAK...icinRochester,Minnesota.AproposaltomergeCytopiaint...
(Date:11/23/2009)..., SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or p...dIDCasExecutiveChairman.Dr.Carterhasasuccessfultra...thef or merChiefExecutiveOfficeratZymoGenetics,inS...Copenhagen,Denmark. ,, (Photo: http://www.newsc...evenReed,IDC,sfounderandChiefExecutiveOfficercomme...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
..., March 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio ...a leading, fully integrated,biotechnology company ...and,marketing biopharmaceutical products primarily...tors has approved a share repurchase program., Th...20 million worth of,its outstanding American Depos...
...ith New Data from Ongoing Studies, CAMBRIDGE, Mas... announced the withdrawal of the European applicat... label to include the,treatment of elderly patient...ion and the data on which it was based were filed ...d by Genzyme last year., In a letter to the Europ...
..., Mass., March 19 MacroChem,Corporation (OTC Bull...of,David P. Luci to the position of Chief Financia...ved as MacroChem,s General Counsel and Vice,Presid...ny in December,2007., Mr. Luci was formerly the C...rger transaction with Genzyme Corporation valued a...
Other Biology Technology:3SBio Inc. Approves Share Repurchase Program 2Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients 2Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients 3MacroChem Appoints David P. Luci as New CFO 2MacroChem Appoints David P. Luci as New CFO 3
(Date:11/23/2009)...ew study provides "incontrovertible evidence" that... of Sumatra about 73,000 years ago deforested much...nter, researchers report. , The volcano ejected ...atmosphere, leaving a crater (now the world,s larg... 35 kilometers wide. Ash from the event has been f...
(Date:11/23/2009)...16, 2009 -- A USDOE and USDA study concluded that ...and cropland pasture could be converted from curre...ch as switchgrass, from which biomass could be har...y viable production of a perennial grass monocultu...e removed annually is expected to require nitrogen...
(Date:11/23/2009)...ew studies reveal in unprecedented detail how the ...e new proteins and guide them toward their destina...ar dynamics flexible fitting (MDFF) to examine the...lecular partners. , The first study, in Procee...ns the intimate signaling between the ribosome and...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Michael Simmons DMD to speak at California Dental Association Meeting 55796 1Michael Simmons DMD to speak at California Dental Association Meeting 55796 2Aircraft Reports Material Expansion and Staff Increase 55791 1Aircraft Reports Material Expansion and Staff Increase 55791 2Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 1Stemedica Achieves Major Milestone Company Receives License to Manufacture Clinical Grade Stem Cells 4924 2
...ntists have discovered that autoimmunity can be tr... cells develop, if T cells fail to recognize just ... The research confirms an emerging view that auto...stem, and not only at the sites where autoimmune d...f type 1 diabetes, or the joints in rheumatoid art...
...tudying the genetics of two closely related specie...sexual reproduction, researchers have shed light o...uction though the joining of distinct sperm and eg...underlying a more primitive system of reproduction...te in sex-specific sperm development, are reported...
...n who improve their own health before pregnancy ha... baby. Three important measures include: , Mana...inherited disorders, obesity, sexually transmitted...ealth through supplements such as folic acid, vacc...or HIV, and , Avoiding alcohol, anti-epileptic ...
Other Biology News:Proteins anchor memories in our brain 2Proteins anchor memories in our brain 3A new male-specific gene in algae unveils an origin of male and female 2Planning ahead: Having the healthiest baby possible 2
...able DNA polymerase obtained by high level express...centration: 5U/ul, Applications: Standard PCR We a...der in serving science. Thermo Fisher Scientific e...ner and safer by providing analytical instruments,...
Fetal Calf Serum from Quad Five
...gh pressure dual piston pump and the WaveQuest Ult...xibility and utra low drift. The WaveQuest provi...y detection and provides superior stability. Hen...pment and for monitoring to the highest of sensiti...
Corning Erlenmeyer Flask, 500 ml, Vent Cap, 50 ml Graduations, 43mm Neck Diam from Sigma-Aldrich
Biology Products: